{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T14:25:20Z","timestamp":1769955920494,"version":"3.49.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["22220102001"],"award-info":[{"award-number":["22220102001"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFF1201400"],"award-info":[{"award-number":["2021YFF1201400"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cheminform"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Deep learning (DL) and machine learning contribute significantly to basic biology research and drug discovery in the past few decades. Recent advances in DL-based generative models have led to superior developments in de novo drug design. However, data availability, deep data processing, and the lack of user-friendly DL tools and interfaces make it difficult to apply these DL techniques to drug design. We hereby present ReMODE (Receptor-based MOlecular DEsign), a new web server based on DL algorithm for target-specific ligand design, which integrates different functional modules to enable users to develop customizable drug design tasks. As designed, the ReMODE sever can construct the target-specific tasks toward the protein targets selected by users. Meanwhile, the server also provides some extensions: users can optimize the drug-likeness or synthetic accessibility of the generated molecules, and control other physicochemical properties; users can also choose a sub-structure\/scaffold as a starting point for fragment-based drug design. The ReMODE server also enables users to optimize the pharmacophore matching and docking conformations of the generated molecules. We believe that the ReMODE server will benefit researchers for drug discovery. ReMODE is publicly available at <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/cadd.zju.edu.cn\/relation\/remode\/\">http:\/\/cadd.zju.edu.cn\/relation\/remode\/<\/jats:ext-link>.<\/jats:p>\n                <jats:p><jats:bold>Graphical Abstract<\/jats:bold><\/jats:p>","DOI":"10.1186\/s13321-022-00665-w","type":"journal-article","created":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T07:05:54Z","timestamp":1670828754000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["ReMODE: a deep learning-based web server for target-specific drug design"],"prefix":"10.1186","volume":"14","author":[{"given":"Mingyang","family":"Wang","sequence":"first","affiliation":[]},{"given":"Jike","family":"Wang","sequence":"additional","affiliation":[]},{"given":"Gaoqi","family":"Weng","sequence":"additional","affiliation":[]},{"given":"Yu","family":"Kang","sequence":"additional","affiliation":[]},{"given":"Peichen","family":"Pan","sequence":"additional","affiliation":[]},{"given":"Dan","family":"Li","sequence":"additional","affiliation":[]},{"given":"Yafeng","family":"Deng","sequence":"additional","affiliation":[]},{"given":"Honglin","family":"Li","sequence":"additional","affiliation":[]},{"given":"Chang-Yu","family":"Hsieh","sequence":"additional","affiliation":[]},{"given":"Tingjun","family":"Hou","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2022,12,12]]},"reference":[{"key":"665_CR1","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1001\/jama.2020.1166","volume":"323","author":"OJ Wouters","year":"2020","unstructured":"Wouters OJ, McKee M, Luyten J (2020) Estimated research and development investment needed to bring a new medicine to market, 2009\u20132018. JAMA, J Am Med Assoc 323:844\u2013853","journal-title":"JAMA, J Am Med Assoc"},{"key":"665_CR2","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.jhealeco.2016.01.012","volume":"47","author":"JA DiMasi","year":"2016","unstructured":"DiMasi JA, Grabowski HG, Hansen RW (2016) Innovation in the pharmaceutical industry: new estimates of R&D costs. J Health Econ 47:20\u201333","journal-title":"J Health Econ"},{"key":"665_CR3","first-page":"516","volume":"324","author":"LW Dominguez","year":"2020","unstructured":"Dominguez LW, Willis JS (2020) Research and development costs of new drugs. J Am Chem Soc 324:516\u2013516","journal-title":"J Am Chem Soc"},{"key":"665_CR4","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.2174\/138161282615200518092124","volume":"26","author":"L Scotti","year":"2020","unstructured":"Scotti L, Scotti MT (2020) Recent advancement in computer-aided drug design. Curr Pharm Des 26:1635\u20131636","journal-title":"Curr Pharm Des"},{"key":"665_CR5","doi-asserted-by":"publisher","first-page":"161","DOI":"10.9734\/jpri\/2021\/v33i31B31704","volume":"33","author":"RT Bhagat","year":"2021","unstructured":"Bhagat RT, Butle SR (2021) Drug repurposing: a review. J Pharm Res Int 33:161\u2013169","journal-title":"J Pharm Res Int"},{"key":"665_CR6","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/BF00126217","volume":"6","author":"H-J B\u00f6hm","year":"1992","unstructured":"B\u00f6hm H-J (1992) LUDI: rule-based automatic design of new substituents for enzyme inhibitor leads. J Comput Aided Mol Des 6:593\u2013606","journal-title":"J Comput Aided Mol Des"},{"key":"665_CR7","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/BF00117275","volume":"9","author":"DE Clark","year":"1995","unstructured":"Clark DE, Frenkel D, Levy SA, Li J, Murray CW, Robson B, Waszkowycz B, Westhead DR (1995) PRO_LIGAND: An approach to de novo molecular design. 1. Application to the design of organic molecules. J Comput Aided Mol Des 9:13\u201332","journal-title":"J Comput Aided Mol Des"},{"key":"665_CR8","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1021\/ci00017a027","volume":"34","author":"VJ Gillet","year":"1994","unstructured":"Gillet VJ, Newell W, Mata P, Myatt G, Sike S, Zsoldos Z, Johnson AP (1994) SPROUT: recent developments in the de novo design of molecules. J Chem Inf Model 34:207\u2013217","journal-title":"J Chem Inf Model"},{"key":"665_CR9","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1021\/jm950792l","volume":"39","author":"DA Pearlman","year":"1996","unstructured":"Pearlman DA, Murcko MA (1996) CONCERTS: dynamic connection of fragments as an approach to de novo ligand design. J Med Chem 39:1651\u20131663","journal-title":"J Med Chem"},{"key":"665_CR10","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1002\/minf.201000019","volume":"29","author":"SR Langdon","year":"2010","unstructured":"Langdon SR, Ertl P, Brown N (2010) Bioisosteric replacement and scaffold hopping in lead generation and optimization. Mol Inf 29:366\u2013385","journal-title":"Mol Inf"},{"key":"665_CR11","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.drudis.2011.10.024","volume":"17","author":"H Sun","year":"2012","unstructured":"Sun H, Tawa G, Wallqvist A (2012) Classification of scaffold-hopping approaches. Drug Discovery Today 17:310\u2013324","journal-title":"Drug Discovery Today"},{"key":"665_CR12","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1023\/A:1008184403558","volume":"14","author":"G Schneider","year":"2000","unstructured":"Schneider G, Lee M-L, Stahl M, Schneider P (2000) De novo design of molecular architectures by evolutionary assembly of drug-derived building blocks. J Comput Aided Mol Des 14:487\u2013494","journal-title":"J Comput Aided Mol Des"},{"key":"665_CR13","doi-asserted-by":"publisher","first-page":"2765","DOI":"10.1021\/jm030809x","volume":"46","author":"HM Vinkers","year":"2003","unstructured":"Vinkers HM, de Jonge MR, Daeyaert FF, Heeres J, Koymans LM, van Lenthe JH, Lewi PJ, Timmerman H, Van Aken K, Janssen PA (2003) Synopsis: synthesize and optimize system in silico. J Med Chem 46:2765\u20132773","journal-title":"J Med Chem"},{"key":"665_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1002380","volume":"8","author":"M Hartenfeller","year":"2012","unstructured":"Hartenfeller M, Zettl H, Walter M, Rupp M, Reisen F, Proschak E, Weggen S, Stark H, Schneider G (2012) DOGS: Reaction-Driven de novo Design of Bioactive Compounds. PLoS Comput Biol 8:e1002380","journal-title":"PLoS Comput Biol"},{"key":"665_CR15","doi-asserted-by":"publisher","first-page":"8985","DOI":"10.1016\/S0040-4020(01)86503-0","volume":"47","author":"Y Nishibata","year":"1991","unstructured":"Nishibata Y, Itai A (1991) Automatic creation of drug candidate structures based on receptor structure. Starting point for artificial lead generation. Tetrahedron 47:8985\u20138990","journal-title":"Tetrahedron"},{"key":"665_CR16","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/BF00126217","volume":"6","author":"H-J B\u00f6hm","year":"1992","unstructured":"B\u00f6hm H-J (1992) LUDI: rule-based automatic design of new substituents for enzyme inhibitor leads. J Comput-Aided Mol Des 6:593\u2013606","journal-title":"J Comput-Aided Mol Des"},{"key":"665_CR17","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/BF00117275","volume":"9","author":"DE Clark","year":"1995","unstructured":"Clark DE, Frenkel D, Levy SA, Li J, Murray CW, Robson B, Waszkowycz B, Westhead DR (1995) PRO_LIGAND: An approach to de novo molecular design .1. Application to the design of organic molecules. J Comput-Aided Mol Des 9:13\u201332","journal-title":"J Comput-Aided Mol Des"},{"key":"665_CR18","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1021\/ci00017a027","volume":"34","author":"VJ Gillet","year":"1994","unstructured":"Gillet VJ, Newell W, Mata P, Myatt G, Sike S, Zsoldos Z, Johnson AP (1994) SPROUT: recent developments in the de novo design of molecules. J Chem Inf Comput Sci 34:207\u2013217","journal-title":"J Chem Inf Comput Sci"},{"key":"665_CR19","doi-asserted-by":"publisher","first-page":"10049","DOI":"10.1016\/j.tet.2008.08.037","volume":"64","author":"AK Agarwal","year":"2008","unstructured":"Agarwal AK, Johnson AP, Fishwick CW (2008) Synthesis of de novo designed small-molecule inhibitors of bacterial RNA polymerase. Tetrahedron 64:10049\u201310054","journal-title":"Tetrahedron"},{"key":"665_CR20","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1021\/jm801220a","volume":"52","author":"H Ji","year":"2009","unstructured":"Ji H, Li H, Mart\u00e1sek P, Roman LJ, Poulos TL, Silverman RB (2009) Discovery of highly potent and selective inhibitors of neuronal nitric oxide synthase by fragment hopping. J Med Chem 52:779\u2013797","journal-title":"J Med Chem"},{"key":"665_CR21","doi-asserted-by":"publisher","first-page":"3900","DOI":"10.1021\/ja0772041","volume":"130","author":"H Ji","year":"2008","unstructured":"Ji H, Stanton BZ, Igarashi J, Li H, Mart\u00e1sek P, Roman LJ, Poulos TL, Silverman RB (2008) Minimal pharmacophoric elements and fragment hopping, an approach directed at molecular diversity and isozyme selectivity. Design of selective neuronal nitric oxide synthase inhibitors. J Am Chem Soc 130:3900\u20133914","journal-title":"J Am Chem Soc"},{"key":"665_CR22","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1016\/j.bmcl.2009.01.034","volume":"19","author":"M Sova","year":"2009","unstructured":"Sova M, \u010cade\u017e G, Turk S, Majce V, Polanc S, Batson S, Lloyd AJ, Roper DI, Fishwick CW, Gobec S (2009) Design and synthesis of new hydroxyethylamines as inhibitors of D-alanyl-D-lactate ligase (VanA) and D-alanyl-D-alanine ligase (DdlB). Bioorg Med Chem Lett 19:1376\u20131379","journal-title":"Bioorg Med Chem Lett"},{"key":"665_CR23","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1021\/jm030543u","volume":"47","author":"AC Pierce","year":"2004","unstructured":"Pierce AC, Rao G, Bemis GW (2004) BREED: Generating novel inhibitors through hybridization of known ligands. Application to CDK2, P38, and HIV protease. J Med Chem 47:2768\u20132775","journal-title":"J Med Chem"},{"key":"665_CR24","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1023\/A:1008184403558","volume":"14","author":"G Schneider","year":"2000","unstructured":"Schneider G, Lee M-L, Stahl M, Schneider P (2000) De novo design of molecular architectures by evolutionary assembly of drug-derived building blocks. J Comput-Aided Mol Des 14:487\u2013494","journal-title":"J Comput-Aided Mol Des"},{"key":"665_CR25","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1517\/17460441.2010.497534","volume":"5","author":"PS Kutchukian","year":"2010","unstructured":"Kutchukian PS, Shakhnovich EI (2010) De novo design: balancing novelty and confined chemical space. Expert Opin Drug Discov 5:789\u2013812","journal-title":"Expert Opin Drug Discov"},{"key":"665_CR26","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1021\/ci970429i","volume":"38","author":"XQ Lewell","year":"1998","unstructured":"Lewell XQ, Judd DB, Watson SP, Hann MM (1998) Recap retrosynthetic combinatorial analysis procedure: a powerful new technique for identifying privileged molecular fragments with useful applications in combinatorial chemistry. J Chem Inf Comput Sci 38:511\u2013522","journal-title":"J Chem Inf Comput Sci"},{"key":"665_CR27","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1126\/science.aat2663","volume":"361","author":"B Sanchez-Lengeling","year":"2018","unstructured":"Sanchez-Lengeling B, Aspuru-Guzik A (2018) Inverse molecular design using machine learning: Generative models for matter engineering. Science 361:360\u2013365","journal-title":"Science"},{"key":"665_CR28","doi-asserted-by":"publisher","first-page":"bbab344","DOI":"10.1093\/bib\/bbab344","volume":"22","author":"Y Cheng","year":"2021","unstructured":"Cheng Y, Gong Y, Liu Y, Song B, Zou Q (2021) Molecular design in drug discovery: a comprehensive review of deep generative models. Briefings Bioinf 22:bbab344","journal-title":"Briefings Bioinf"},{"key":"665_CR29","doi-asserted-by":"publisher","first-page":"1700111","DOI":"10.1002\/minf.201700111","volume":"37","author":"A Gupta","year":"2018","unstructured":"Gupta A, Mueller AT, Huisman BJH, Fuchs JA, Schneider P, Schneider G (2018) Generative Recurrent Networks for De Novo Drug Design. Mol Inf 37:1700111","journal-title":"Mol Inf"},{"key":"665_CR30","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/s42256-020-0160-y","volume":"2","author":"M Moret","year":"2020","unstructured":"Moret M, Friedrich L, Grisoni F, Merk D, Schneider G (2020) Generative molecular design in low data regimes. Nat Mach Intell 2:171\u2013180","journal-title":"Nat Mach Intell"},{"key":"665_CR31","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1021\/acscentsci.7b00512","volume":"4","author":"MHS Segler","year":"2018","unstructured":"Segler MHS, Kogej T, Tyrchan C, Waller MP (2018) Generating Focused Molecule Libraries for Drug Discovery with Recurrent Neural Networks. ACS Cent Sci 4:120\u2013131","journal-title":"ACS Cent Sci"},{"key":"665_CR32","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13065-021-00737-2","volume":"15","author":"MVS Santana","year":"2021","unstructured":"Santana MVS, Silva-Jr FP (2021) De novo design and bioactivity prediction of SARS-CoV-2 main protease inhibitors using recurrent neural network-based transfer learning. BMC Chem 15:8","journal-title":"BMC Chem"},{"key":"665_CR33","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1021\/acscentsci.7b00572","volume":"4","author":"R Gomez-Bombarelli","year":"2018","unstructured":"Gomez-Bombarelli R, Wei JN, Duvenaud D, Hernandez-Lobato JM, Sanchez-Lengeling B, Sheberla D, Aguilera-Iparraguirre J, Hirzel TD, Adams RP, Aspuru-Guzik A (2018) Automatic Chemical Design Using a Data-Driven Continuous Representation of Molecules. ACS Cent Sci 4:268\u2013276","journal-title":"ACS Cent Sci"},{"key":"665_CR34","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1021\/acs.jcim.8b00706","volume":"59","author":"M Skalic","year":"2019","unstructured":"Skalic M, Jim\u00e9nez J, Sabbadin D, De Fabritiis G (2019) Shape-based generative modeling for de novo drug design. J Chem Inf Model 59:1205\u20131214","journal-title":"J Chem Inf Model"},{"key":"665_CR35","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1038\/s41587-019-0224-x","volume":"37","author":"A Zhavoronkov","year":"2019","unstructured":"Zhavoronkov A, Ivanenkov YA, Aliper A, Veselov MS, Aladinskiy VA, Aladinskaya AV, Terentiev VA, Polykovskiy DA, Kuznetsov MD, Asadulaev A et al (2019) Deep learning enables rapid identification of potent DDR1 kinase inhibitors. Nat Biotechnol 37:1038","journal-title":"Nat Biotechnol"},{"key":"665_CR36","doi-asserted-by":"publisher","first-page":"3098","DOI":"10.1021\/acs.molpharmaceut.7b00346","volume":"14","author":"A Kadurin","year":"2017","unstructured":"Kadurin A, Nikolenko S, Khrabrov K, Aliper A, Zhavoronkov A (2017) druGAN: an advanced generative adversarial autoencoder model for de novo generation of new molecules with desired molecular properties in silico. Mol Pharmaceutics 14:3098\u20133104","journal-title":"Mol Pharmaceutics"},{"key":"665_CR37","unstructured":"Guimaraes GL, Sanchez-Lengeling B, Outeiral C, Farias PLC, Aspuru-Guzik A: Objective-Reinforced Generative Adversarial Networks (ORGAN) for Sequence Generation Models. arXiv 2018:1705.10843."},{"key":"665_CR38","doi-asserted-by":"crossref","unstructured":"Sanchez-Lengeling B, Outeiral C, Guimaraes GL, Aspuru-Guzik A: Optimizing distributions over molecular space. An Objective-Reinforced Generative Adversarial Network for Inverse-design Chemistry (ORGANIC). chemrxiv 2017:5309668.","DOI":"10.26434\/chemrxiv.5309668"},{"key":"665_CR39","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1038\/s42256-021-00403-1","volume":"3","author":"J Wang","year":"2021","unstructured":"Wang J, Hsieh C-Y, Wang M, Wang X, Wu Z, Jiang D, Liao B, Zhang X, Yang B, He Q et al (2021) Multi-constraint molecular generation based on conditional transformer, knowledge distillation and reinforcement learning. Nat Mach Intell 3:914\u2013922","journal-title":"Nat Mach Intell"},{"key":"665_CR40","doi-asserted-by":"publisher","first-page":"4282","DOI":"10.1021\/acs.molpharmaceut.9b00634","volume":"16","author":"M Skalic","year":"2019","unstructured":"Skalic M, Sabbadin D, Sattarov B, Sciabola S, De Fabritiis G (2019) From Target to Drug: Generative Modeling for the Multimodal Structure-Based Ligand Design. Mol Pharmaceutics 16:4282\u20134291","journal-title":"Mol Pharmaceutics"},{"key":"665_CR41","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1093\/bib\/bbaa161","volume":"22","author":"Q Bai","year":"2021","unstructured":"Bai Q, Tan S, Xu T, Liu H, Huang J, Yao X (2021) MolAICal: a soft tool for 3D drug design of protein targets by artificial intelligence and classical algorithm. Briefings Bioinf 22:161","journal-title":"Briefings Bioinf"},{"key":"665_CR42","doi-asserted-by":"publisher","first-page":"3240","DOI":"10.1021\/acs.jcim.0c01494","volume":"61","author":"MY Xu","year":"2021","unstructured":"Xu MY, Ran T, Chen HM (2021) De novo molecule design through the molecular generative model conditioned by 3D Information of Protein Binding Sites. J Chem Inf Model 61:3240\u20133254","journal-title":"J Chem Inf Model"},{"key":"665_CR43","doi-asserted-by":"publisher","first-page":"13664","DOI":"10.1039\/D1SC04444C","volume":"12","author":"Y Li","year":"2021","unstructured":"Li Y, Pei J, Lai L (2021) Structure-based de novo drug design using 3D deep generative models. Chem Sci 12:13664\u201313675","journal-title":"Chem Sci"},{"key":"665_CR44","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1039\/D1SC05976A","volume":"13","author":"M Ragoza","year":"2022","unstructured":"Ragoza M, Masuda T, Koes DR (2022) Generating 3D molecules conditional on receptor binding sites with deep generative models. Chem Sci 13:2701\u20132713","journal-title":"Chem Sci"},{"key":"665_CR45","doi-asserted-by":"publisher","first-page":"12166","DOI":"10.1021\/acs.jpcb.1c06437","volume":"125","author":"RP Joshi","year":"2021","unstructured":"Joshi RP, Gebauer NW, Bontha M, Khazaieli M, James RM, Brown JB, Kumar N (2021) 3D-Scaffold: A Deep Learning Framework to Generate 3D Coordinates of Drug-like Molecules with Desired Scaffolds. J Phys Chem B 125:12166\u201312176","journal-title":"J Phys Chem B"},{"key":"665_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-022-28526-y","volume":"13","author":"NW Gebauer","year":"2022","unstructured":"Gebauer NW, Gastegger M, Hessmann SS, M\u00fcller K-R, Sch\u00fctt KT (2022) Inverse design of 3d molecular structures with conditional generative neural networks. Nat Commun 13:1\u201311","journal-title":"Nat Commun"},{"key":"665_CR47","unstructured":"Gebauer N, Gastegger M, Sch\u00fctt K: Symmetry-adapted generation of 3d point sets for the targeted discovery of molecules. Advances in Neural Information Processing Systems 2019, 32."},{"key":"665_CR48","doi-asserted-by":"publisher","first-page":"14577","DOI":"10.1039\/D1SC02436A","volume":"12","author":"F Imrie","year":"2021","unstructured":"Imrie F, Hadfield TE, Bradley AR, Deane CM (2021) Deep generative design with 3D pharmacophoric constraints. Chem Sci 12:14577\u201314589","journal-title":"Chem Sci"},{"key":"665_CR49","doi-asserted-by":"publisher","first-page":"9478","DOI":"10.1021\/acs.jmedchem.2c00732","volume":"65","author":"M Wang","year":"2022","unstructured":"Wang M, Hsieh C-Y, Wang J, Wang D, Weng G, Shen C, Yao X, Bing Z, Li H, Cao D et al (2022) RELATION: A Deep Generative Model for Structure-Based De Novo Drug Design. J Med Chem 65:9478\u20139492","journal-title":"J Med Chem"},{"key":"665_CR50","doi-asserted-by":"crossref","unstructured":"Sun B, Feng J, Saenko K: Return of frustratingly easy domain adaptation. In: Proceedings of the AAAI Conference on Artificial Intelligence: 2016.","DOI":"10.1609\/aaai.v30i1.10306"},{"key":"665_CR51","doi-asserted-by":"crossref","unstructured":"Tzeng E, Hoffman J, Darrell T, Saenko K: Simultaneous deep transfer across domains and tasks. In: Proceedings of the IEEE international conference on computer vision: 2015. 4068\u20134076.","DOI":"10.1109\/ICCV.2015.463"},{"key":"665_CR52","doi-asserted-by":"publisher","first-page":"8683","DOI":"10.1021\/acs.jmedchem.9b02147","volume":"63","author":"C Cai","year":"2020","unstructured":"Cai C, Wang S, Xu Y, Zhang W, Tang K, Ouyang Q, Lai L, Pei J (2020) Transfer Learning for Drug Discovery. J Med Chem 63:8683\u20138694","journal-title":"J Med Chem"},{"key":"665_CR53","first-page":"1633","volume":"10","author":"ME Taylor","year":"2009","unstructured":"Taylor ME, Stone P (2009) Transfer Learning for Reinforcement Learning Domains: A Survey. J Mach Learn Res 10:1633\u20131685","journal-title":"J Mach Learn Res"},{"key":"665_CR54","first-page":"06019","volume":"1608","author":"K Bousmalis","year":"2016","unstructured":"Bousmalis K, Trigeorgis G, Silberman N, Krishnan D, Erhan D (2016) Domain separation networks arXiv 1608:06019","journal-title":"Domain separation networks arXiv"},{"key":"665_CR55","doi-asserted-by":"crossref","unstructured":"Eberhardt J, Santos-Martins D, Tillack AF, Forli S: AutoDock Vina 1.2.0: New Docking Methods, Expanded Force Field, and Python Bindings. J Chem Inf Model 2021, 61:3891\u20133898.","DOI":"10.1021\/acs.jcim.1c00203"},{"key":"665_CR56","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1039\/C9SC04026A","volume":"11","author":"R-R Griffiths","year":"2020","unstructured":"Griffiths R-R, Hernandez-Lobato JM (2020) Constrained Bayesian optimization for automatic chemical design using variational autoencoders. Chem Sci 11:577\u2013586","journal-title":"Chem Sci"},{"key":"665_CR57","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1021\/ci049885e","volume":"45","author":"G Wolber","year":"2005","unstructured":"Wolber G, Langer T (2005) LigandScout: 3-d pharmacophores derived from protein-bound Ligands and their use as virtual screening filters. J Chem Inf Model 45:160\u2013169","journal-title":"J Chem Inf Model"},{"key":"665_CR58","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1007\/s10822-006-9078-7","volume":"20","author":"G Wolber","year":"2006","unstructured":"Wolber G, Dornhofer AA, Langer T (2006) Efficient overlay of small organic molecules using 3D pharmacophores. J Comput-Aided Mol Des 20:773\u2013788","journal-title":"J Comput-Aided Mol Des"},{"key":"665_CR59","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1021\/ci3001277","volume":"52","author":"JJ Irwin","year":"2012","unstructured":"Irwin JJ, Sterling T, Mysinger MM, Bolstad ES, Coleman RG (2012) ZINC: A Free Tool to Discover Chemistry for Biology. J Chem Inf Model 52:1757\u20131768","journal-title":"J Chem Inf Model"},{"key":"665_CR60","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1021\/acs.jcim.5b00559","volume":"55","author":"T Sterling","year":"2015","unstructured":"Sterling T, Irwin JJ (2015) ZINC 15 \u2013 Ligand Discovery for Everyone. J Chem Inf Model 55:2324\u20132337","journal-title":"J Chem Inf Model"},{"key":"665_CR61","doi-asserted-by":"publisher","first-page":"D1045","DOI":"10.1093\/nar\/gkv1072","volume":"44","author":"MK Gilson","year":"2016","unstructured":"Gilson MK, Liu T, Baitaluk M, Nicola G, Hwang L, Chong J (2016) BindingDB in 2015: A public database for medicinal chemistry, computational chemistry and systems pharmacology. Nucleic Acids Res 44:D1045\u2013D1053","journal-title":"Nucleic Acids Res"},{"key":"665_CR62","doi-asserted-by":"publisher","first-page":"W612","DOI":"10.1093\/nar\/gkv352","volume":"43","author":"M Davies","year":"2015","unstructured":"Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP (2015) ChEMBL web services: streamlining access to drug discovery data and utilities. Nucleic Acids Res 43:W612\u2013W620","journal-title":"Nucleic Acids Res"},{"key":"665_CR63","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/nar\/28.1.235","volume":"28","author":"HM Berman","year":"2000","unstructured":"Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE (2000) The Protein Data Bank. Nucleic Acids Res 28:235\u2013242","journal-title":"Nucleic Acids Res"},{"key":"665_CR64","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s13059-019-1758-4","volume":"20","author":"D Otasek","year":"2019","unstructured":"Otasek D, Morris JH, Boucas J, Pico AR, Demchak B (2019) Cytoscape Automation: empowering workflow-based network analysis. Genome Biol 20:185","journal-title":"Genome Biol"},{"key":"665_CR65","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/nmeth.2212","volume":"9","author":"R Saito","year":"2012","unstructured":"Saito R, Smoot ME, Ono K, Ruscheinski J, Wang P-L, Lotia S, Pico AR, Bader GD, Ideker T (2012) A travel guide to Cytoscape plugins. Nat Methods 9:1069\u20131076","journal-title":"Nat Methods"},{"key":"665_CR66","doi-asserted-by":"crossref","unstructured":"Su X, Hu L, You Z, Hu P, Wang L, Zhao B: A deep learning method for repurposing antiviral drugs against new viruses via multi-view nonnegative matrix factorization and its application to SARS-CoV-2. Briefings Bioinf 2021, 23:bbab526.","DOI":"10.1093\/bib\/bbab526"},{"key":"665_CR67","doi-asserted-by":"crossref","unstructured":"Su X, Hu L, You Z, Hu P, Zhao B: Attention-based Knowledge Graph Representation Learning for Predicting Drug-drug Interactions. Briefings Bioinf 2022, 23:bbac140.","DOI":"10.1093\/bib\/bbac140"},{"key":"665_CR68","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1039\/c2mb00002d","volume":"8","author":"X Chen","year":"2012","unstructured":"Chen X, Liu M-X, Yan G-Y (2012) Drug-target interaction prediction by random walk on the heterogeneous network. Mol BioSyst 8:1970\u20131978","journal-title":"Mol BioSyst"},{"key":"665_CR69","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1093\/bib\/bbaa044","volume":"22","author":"T Zhao","year":"2021","unstructured":"Zhao T, Hu Y, Valsdottir LR, Zang T, Peng J (2021) Identifying drug-target interactions based on graph convolutional network and deep neural network. Briefings Bioinf 22:2141\u20132150","journal-title":"Briefings Bioinf"},{"key":"665_CR70","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1002\/cncr.29139","volume":"121","author":"CE Steuer","year":"2015","unstructured":"Steuer CE, Khuri FR, Ramalingam SS (2015) The next generation of epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of lung cancer. Cancer 121:E1\u2013E6","journal-title":"Cancer"}],"container-title":["Journal of Cheminformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13321-022-00665-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13321-022-00665-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13321-022-00665-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T22:16:00Z","timestamp":1671142560000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcheminf.biomedcentral.com\/articles\/10.1186\/s13321-022-00665-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,12]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["665"],"URL":"https:\/\/doi.org\/10.1186\/s13321-022-00665-w","relation":{},"ISSN":["1758-2946"],"issn-type":[{"value":"1758-2946","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,12]]},"assertion":[{"value":"14 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"84"}}